Webinar Opportunity
Nigel Clarke, PhD explains the science behind new AD Biomarker testing available from Quest Diagnostics.
Exome with CNV Evaluation
Exome with CNV Evaluation is used when the conditions are so rare no diagnostic test exists, targeted testing is impractical, or definitive tests are unavailable or non-informative.
Breadth of Testing Options
Many neurological disorders have similar symptoms and may have unclear causes, making definitive diagnosis difficult at times. Quest Diagnostics offers a comprehensive testing menu including advanced neurological diagnostic assays tests.
Peripheral Neuropathy Testing
Over 10 million people in the United States suffer from neuropathy. Due to the diverse causes of neuropathy, laboratory testing is often required for diagnosis or etiologic identification.
Earlier Diagnosis
Early diagnosis of Alzheimer-type dementia is a crucial factor in its management. We offer tests to aid in the diagnosis of Alzheimer’s and other neurodegenerative disorders.
Quest Diagnostics Interpretation Guides
Find information relating to test selection, utilization and interpretation. All information is based on peer-reviewed publications, practice guidelines, or other reputable sources.
